Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
OPERATING ACTIVITIES:
Consolidated net loss	$ (1,162)	$ (277)
Adjustments to reconcile consolidated net income to net cash provided by (used in) operating activities:
Bad debt expense	64	(4)
Depreciation and amortization	541	180
Stock-based compensation expense	212	139
Amortization of debt issuance cost	2	0
Tax payments related to shares cancelled for vested restricted stock awards	(7)	(13)
Deferred income taxes	(136)	23
Changes in operating assets and liabilities:
Trade accounts receivable	843	3,013
Inventories	117	(2,299)
Other current assets	2,665	(693)
Right of use assets	383	(15)
Accounts payable	(803)	(122)
Accrued expenses	(3,246)	625
Deferred revenue	1,133	0
Income taxes payable	283	0
Net cash provided by operating activities	889	557
INVESTING ACTIVITIES:
Capital expenditures	(1,130)	(103)
Net cash used in investing activities	(1,130)	(103)
FINANCING ACTIVITIES:
Proceeds from exercise of stock options	85	0
Term Loan payments	(606)	0
Net cash used in financing activities	(521)	0
Net (decrease) increase in cash and cash equivalents	(762)	454
Cash and cash equivalents, beginning of period	4,532	13,053
Cash and cash equivalents, end of period	3,770	13,507
Supplemental cash flow information – income taxes paid	$ 0	$ 156